Abstract
Abstract 3239: CTX-5861 mediated SIRPα blockade combines with tumor targeting antibodies, checkpoint blockade and/or CD137 agonism to elicit curative anti-tumor activity in syngeneic mouse models
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have